Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc       

PFIZER INC

SummaryNewsCalendarCompany 
Business Summary
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.
Managers
NameAgeSinceTitle
Albert Bourla572020Chairman, Chief Executive & Operating Officer
Frank D'Amelio612010Chief Financial Officer & EVP-Business Operations
Lidia L. Fonseca50-Executive VP, Chief Digital & Technology Officer
Wyllie Don Cornwell721997Independent Director
Suzanne Nora Johnson612007Independent Director
James Marshall Kilts712007Independent Director
Helen H. Hobbs, Dr.662011Independent Director
Shantanu Narayen55-Lead Independent Director
James Smith592014Independent Director
Joseph Echevarria622015Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,399,962,916 5,557,319,394 59.1% 3,840,000,000 40.9% 59.1%
Shareholders
NameEquities%
The Vanguard Group, Inc. 430,369,266 7.74%
SSgA Funds Management, Inc. 289,091,326 5.20%
Capital Research & Management Co. (World Investors) 259,186,297 4.66%
Wellington Management Co. LLP 250,854,569 4.51%
Capital Research & Management Co. 142,320,700 2.56%
BlackRock Fund Advisors 134,389,509 2.42%
Putnam LLC 101,553,726 1.83%
Geode Capital Management LLC 89,213,456 1.61%
Northern Trust Investments, Inc.(Investment Management) 68,734,012 1.24%
Norges Bank Investment Management 59,372,776 1.07%
Holdings
NameEquities%Valuation
Pfizer Limited (500680) 29,243,04263.9%1,967,096,093 USD
SpringWorks Therapeutics, Inc. (SWTX) 4,593,8479.44%266,397,188 USD
CStone Pharmaceuticals (2616) 115,928,8039.90%170,122,041 USD
Cortexyme, Inc. (CRTX) 2,879,9739.77%137,864,308 USD
Morphic Holding, Inc. (MORF) 2,528,8358.25%68,050,950 USD
Sosei Group Corporation (4565) 1,885,1362.34%22,486,751 USD
NextCure, Inc. (NXTC) 1,970,7597.15%19,037,532 USD
Wave Life Sciences Ltd. (WVE) 1,875,0004.16%13,256,250 USD
ESSA Pharma Inc. (EPI) 1,675,0005.77%10,217,500 USD
RaQualia Pharma Inc. (4579) 743,0003.55%6,432,129 USD
Company contact information
Pfizer Inc.
235 East 42nd Street
New York, NY 10017-5755

Phone : +1.212.733.2323
Web : http://www.pfizer.com